In conclusion, our results suggest that NDRG1 may play an important role in mediating the anti-tumor activity of DpdtC in HER2-overexpressed cancer via selective suppression of the HER2-ERK1/2 pathway. The gene discussed is ERBB2; the disease is neoplasm.